or
forgot password
  • cancer clinical trials in omaha, NE

  • Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Omaha Veterans Administration Medical Center
    Adenocarcinoma of the Prostate, Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Lung Cancer
    Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    Lymphoma
    Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    CCOP - Missouri Valley Cancer Consortium

    Trial Locations
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Breast Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Creighton University Medical Center

    Trial Locations
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Lymphoma, T-Cell, Peripheral
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Colorectal Cancer
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    Immanuel Medical Center

    Trial Locations
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Lakeside Hospital
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Alegent Health Immanuel Medical Center

    Trial Locations
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Light Chain Deposition Disease, Smoldering Multiple Myeloma